Skip to main content

Lung Adenocarcinomas with Isolated TP53 Mutation: A Comprehensive Clinical, Cytopathologic and Molecular Characterization

Tracking # 20-1224572

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

Presenter(s): Heather Chen-Yost, MD Rachelle Mendoza, MD Anna Biernacka, MD, PhD The eJournal is an online pathology journal club that reviews current articles from a peer-reviewed cytopathology Journal. Participants will be able to review the journal article, commentary and webinar from the contributing author. This is a great self-assessment, teaching and continuing education tool. TARGET AUDIENCE This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community. LEARNING OBJECTIVES Describe demographic, cytomorphologic, and immunohistochemical findings in lung adenocarcinomas with isolated TP53 mutations Highlight molecular findings in lung adenocarcinomas with isolated TP53 mutations and their associations with IHC findings Explain the significance of TP53 mutations in lung carcinomas

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General (Cytology)

Clinical Laboratory Supervisor

1h General (Cytology)

Clinical Laboratory Technician

1h General (Cytology)

Clinical Laboratory Technologist

1h General (Cytology)

Public Health Director

1h General (Cytology)

Public Health Supervisor

1h General (Cytology)

Public Health Technologist

1h General (Cytology)

Disclosure statements

The presenters have no conflicts of interest or financial relationships to disclose.